CD14 and Sepsis: Skjeflo and coworkers (48) demonstrated that simultaneous upstream inhibition of complement and CD14 efficiently attenuated S. aureus-induced inflammation in a human whole-blood model, suggesting that double blockade might be a promising treatment of sepsis.